A Nonsteroidal Novel Formulation Targeting Inflammatory and Pruritus-Related Mediators Modulates Experimental Allergic Contact Dermatitis

INTRODUCTION: A major clinical challenge in treating allergic contact dermatitis (ACD) is that the first line of treatment is based on the use of corticosteroids. In this study, we aimed to develop a formulation that is devoid of steroids. METHODS: We used mouse ears treated with dinitrofluorobenzen...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, William C., López, Virginia García, Bhattacharjee, Surjyadipta, Gil, David Rodríguez, Díaz, Javier Alcover, de la Losa, Fernando Pineda, Peláez, Ricardo Palacios, Ferrer, Concha Tiana, Bacchini, Gabriela Silvina, Jun, Bokkyoo, Varoqui, Hélène, Bazan, Nicolas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825328/
https://www.ncbi.nlm.nih.gov/pubmed/29453524
http://dx.doi.org/10.1007/s13555-018-0223-8

Ejemplares similares

Ejemplares similares